Patents by Inventor Sharon Baughman

Sharon Baughman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosages for treatment with anti-EGFR antibodies
    Publication number: 20060210561
    Abstract: The present invention concerns dosages for treatment of human cancer patients with an anti-Epidermal Growth Factor Receptor (EGFR) antibody.
    Type: Application
    Filed: May 31, 2006
    Publication date: September 21, 2006
    Inventors: Sharon Baughman, Steven Shak
  • Macrocyclic ligands and complexes
    Patent number: 5652361
    Abstract: A group of functionalized polyaminocarboxylate chelants that form complexes with rare earth-type metal ions are disclosed. The complexes, covalently attached to an antibody or antibody fragment, can be used for therapeutic and/or diagnostic purposes.
    Type: Grant
    Filed: March 8, 1993
    Date of Patent: July 29, 1997
    Assignee: The Dow Chemical Company
    Inventors: Jaime Simon, Joseph R. Garlich, Garry E. Kiefer, Kenneth McMillan, Richard Keith Frank, William F. Goeckeler, William A. Fordyce, Roberta C. Cheng, William J. Kruper, Jr., Sharon Baughman, David A. Wilson